Implantable Pulse Generator Market 2024: Competitive Landscape and Analysis

The implantable pulse generator global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Implantable Pulse Generator Market, 2024The implantable pulse generator global market report 2024

Market Size – The implantable pulse generator market size has grown strongly in recent years. It will grow from $99.52 billion in 2023 to $107.09 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%.  The growth in the historic period can be attributed to a large number of home healthcare facilities, higher adoption of neuromodulation in disease management, higher diagnosis rate of the patients, increasing usage of medical devices and higher patient awareness.
The implantable pulse generator market size is expected to see strong growth in the next few years. It will grow to $144.31 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.  The growth in the forecast period can be attributed to increasing healthcare expenditure, patient preferences for less intrusive treatments, favorable reimbursement policies, expansion of application areas, and growing application of implants in therapies. Major trends in the forecast period include miniaturization of devices, enhanced battery life, development of wireless connectivity, smart implantable devices, and integration of artificial intelligence and machine learning.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

Scope Of Implantable Pulse Generator MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Implantable Pulse Generator Market Overview
Market Drivers -A rise in the incidence of neurological disorders is projected to boost the growth of the implantable pulse generator market in the coming years. Neurological disorders encompass conditions that impact the brain, spinal cord, and nervous system, affecting various functions such as movement, sensation, and cognition. The increase in neurological disorder cases can often be attributed to aging populations, lifestyle changes, environmental factors, and advancements in diagnostic techniques. Implantable pulse generators address these disorders by delivering targeted electrical impulses that modulate abnormal neural activity, alleviating symptoms. For instance, the Parkinson Foundation noted in December 2022 that the number of individuals with Parkinson’s disease (PD) in the U.S. was 930,000 by 2020, with projections indicating this figure could rise to 1.2 million by 2030. Consequently, the escalating incidence of neurological disorders is driving the growth of the implantable pulse generator market through 2023, into 2024, and is expected to continue expanding by 2028.

Market Trends – Major companies operating in the implantable pulse generator market are increasing their focus on developing advanced neuromodulation devices to enhance treatment efficacy, improve patient outcomes, and expand the applicability of these devices across a broader range of neurological conditions. A neuromodulation device is a medical device designed to alter nerve activity by delivering electrical or pharmaceutical agents directly to targeted areas of the nervous system. For instance, in November 2022, CVRx Inc., a US-based medical device company, launched the new Barostim NEO2 IPG, an implantable pulse generator for patients undergoing therapy. The Barostim system uses neuromodulation to improve heart failure symptoms by delivering electrical pulses to the baroreceptors in the carotid artery wall. This stimulation activates the body’s baroreflex, triggering an autonomic response in the heart. The therapy aims to restore balance to the autonomic nervous system and alleviate heart failure symptoms.

The implantable pulse generator market covered in this report is segmented –
1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices
2) By Charging Type: Rechargeable, Non Rechargeable
3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

Get an inside scoop of the implantable pulse generator market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

Regional Insights – North America was the largest region in the implantable pulse generator market in 2023. The regions covered in the implantable pulse generator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies – Major companies in the market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings Corporation, Livanova plc, Inspire Medical Systems Inc., Nevro Corp, Impulse Dynamics Ltd., Valtronic Inc., NeuroPace Inc., SPR Therapeutics Inc., Stimwave LLC, SetPoint Medical, ReShape Lifesciences Inc., Synapse Biomedical Inc., Nuvectra Medical Inc., NeuroSigma Inc., Nalu Medical Inc., MainStay Medical International PLC, Dextronix Inc., BioControl Medical Inc.

Table of Contents 1. Executive Summary2. Implantable Pulse Generator Market Report Structure3. Implantable Pulse Generator Market Trends And Strategies4. Implantable Pulse Generator Market – Macro Economic Scenario5. Implantable Pulse Generator Market Size And Growth…..27. Implantable Pulse Generator Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model